First U.K. Trial Volunteer to Get Experimental Ebola Shot
(Reuters) – The first human volunteer in a fast-tracked British safety trial of an experimental vaccine to fight Ebola is to be injected with the shot next week, organisers of the trial said on Friday.
The candidate Ebola vaccine is being co-developed by the United States National Institutes of Health and the British drugmaker GlaxoSmithKline.
The British trial, which will ultimately involve 60 people, is part of a series of safety tests of potential vaccines aimed at preventing infection with the virus that has killed more than 2,400 people in West Africa this year in the world’s largest Ebola outbreak on record.
The trial will be led by Professor Adrian Hill of the Jenner Institute at Oxford University, which said on Friday the first shot is scheduled to be given to a human volunteer next week.